Tofacitinib extended-release tablets are indicated to treat moderate to severely active rheumatoid arthritis in those whom methotrexate did not work well or cannot be tolerated.
DSN talks to Camber Pharmaceuticals president Kon Ostaficiuk about the company's pandemic efforts and the recent additions to its pharmaceutical and store-brand OTC offerings.
AAM noted that its members have worked hard to enhance patient access to affordable treatments, such as manufacturing dexamethasone, throughout the pandemic.
Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report.
